However, Hu and colleagues discovered for the first time that the HIF-1α is responsible for the control of glycolytic gene transcription and, as a result, that it stimulates the glycolysis pathway in cancer progression, whereas the HIF-2α is not responsible [12]. The gene discussed is HIF1A; the disease is cancer.